Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Metabolic disorders
Research
Turkish bank invests $39M in Harvard next-gen obesity antibodies
Once the antibodies are ready, a new biotech called Enlila will launch and may license them for clinical development.
Darren Incorvaia
Jun 16, 2025 1:07pm
Boy with rare disease 'thriving' after 1st custom gene therapy
May 15, 2025 1:00pm
Relmada reconsiders plans to test psilocybin for obesity
Mar 28, 2025 10:00am
Novo bets up to $354M per target on Gensaic’s delivery tech
Mar 3, 2025 8:37am
Lilly inks $50M deal for biotech's FXR program
Feb 26, 2025 5:35am
Novo inks $50M metabolic disease pact with genomics biotech
Jan 7, 2025 10:35am
